Avelumab is an immunotherapy drug that is currently in development for the treatment of NSCLC. A clinical trial involving 2,200 patients – 53 of whom [...]
A new study, led by Loyola Medicine thoracic surgeon, Wickii Vigneswaran, MD, suggests that patients with malignant pleural mesothelioma who undergo a specific type of [...]
Apoptosis is the natural process in which biochemical events change the characteristics of damaged or unhealthy cells, causing them to close down and die. Cell [...]
Scientists in the University of Rome’s Department of Clinical Sciences and Translational Medicine have recently reviewed 150 studies on the effects of polyphenols on cancer [...]
